Email Us Here

Eleison Announces the Issuance of New Patents for Glufosfamide and ILC

Eleison Pharmaceuticals LLC, a specialty pharmaceutical company developing life-saving therapeutics for rare cancers, has announced the issuance of United States Patents, No. 9,205,098 and No. 9,107,824.